UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

New developments in the treatment of squamous cell lung cancer

Current opinion in oncology, 2014-03, Vol.26 (2), p.152-158

Filipits, Martin

2014

Volltextzugriff (PDF)

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

The New England journal of medicine, 2013-03, Vol.368 (12), p.1101-1110

2013

Volltextzugriff (PDF)

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-08, Vol.17 (8), p.1064-1075

2015

Volltextzugriff (PDF)

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2016-04, Vol.34 (11), p.1223-1230

2016

Volltextzugriff (PDF)

Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score

Journal of clinical oncology, 2015-03, Vol.33 (8), p.916-922

2015

Volltextzugriff (PDF)

EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

Clinical cancer research, 2009-07, Vol.15 (14), p.4554-4560

2009

Volltextzugriff (PDF)

From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer

ESMO open, 2019-09, Vol.4 (5), p.e000548-e000548, Article e000548

2019

Volltextzugriff (PDF)

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Clinical cancer research, 2011-09, Vol.17 (18), p.6012-6020

2011

Volltextzugriff (PDF)

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2173-2181

2013

Volltextzugriff (PDF)

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib

Targeted oncology, 2021-01, Vol.16 (1), p.77-84

2021

Volltextzugriff (PDF)

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

The New England journal of medicine, 2006-09, Vol.355 (10), p.983-991

2006

Volltextzugriff (PDF)

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

Journal of thoracic oncology, 2010-10, Vol.5 (10), p.1706-1713

2010

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy

Cancers, 2023-07, Vol.15 (13), p.3528

2023

Volltextzugriff (PDF)

Molecularly targeted therapies in cervical cancer. A systematic review

Gynecologic oncology, 2012-08, Vol.126 (2), p.291-303

2012

Volltextzugriff (PDF)

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-300, Article 300

2023

Volltextzugriff (PDF)

Predictive markers in the adjuvant therapy of non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2011-12, Vol.74 (3), p.355-363

2011

Volltextzugriff (PDF)

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Clinical cancer research, 2013-01, Vol.19 (2), p.500-507

2013

Volltextzugriff (PDF)

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer

Clinical cancer research, 2017-07, Vol.23 (14), p.3676-3683

2017

Volltextzugriff (PDF)

Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA

Experimental and molecular pathology, 2021-12, Vol.123, p.104685-104685, Article 104685

2021

Volltextzugriff (PDF)

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients

Clinical Medicine Insights. Oncology, 2021, Vol.15, p.1179554921993072-1179554921993072

2021

Volltextzugriff (PDF)

Targeted therapies in lung cancer

Current pharmaceutical design, 2009, Vol.15 (2), p.188-206

2009

Volltextzugriff (PDF)

Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study

Clinical cancer research, 2018-07, Vol.24 (13), p.3079-3086

2018

Volltextzugriff (PDF)

mTOR inhibitors in breast cancer: A systematic review

Gynecologic oncology, 2012-12, Vol.127 (3), p.662-672

2012

Volltextzugriff (PDF)

Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test

BMC cancer, 2012-10, Vol.12 (1), p.456-456, Article 456

2012

Volltextzugriff (PDF)

Adjuvant Therapy in Patients With Completely Resected Non–small-cell Lung Cancer: Current Status and Perspectives

Clinical lung cancer, 2019-01, Vol.20 (1), p.1-6

2019

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(178)
Mit Volltextzugriff
(172)

Publikationsform

Artikel
(193)

Sprache

Englisch
(188)
Japanisch
(26)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(129)
Life Sciences & Biomedicine
(126)
Humans
(105)
Oncology
(101)
Female
(78)
Middle Aged
(63)
Aged
(55)
Prognosis
(52)
Biological And Medical Sciences
(46)
Medical Sciences
(45)
Male
(41)
Adult
(40)
Tumors
(34)
Breast Cancer
(28)
Aged, 80 And Over
(27)
Antineoplastic Agents
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(24)
Lung Neoplasms - Drug Therapy
(24)
Chemotherapy
(22)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

New developments in the treatment of squamous cell lung cancer

ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score

EGFR/KRAS/BRAF Mutations in Primary Lung Adenocarcinomas and Corresponding Locoregional Lymph Node Metastases

From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer

A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

Epidermal Growth Factor Receptor T790M Mutation Testing in Non-Small Cell Lung Cancer: An International Collaborative Study to Assess Molecular EGFR T790M Testing in Liquid Biopsy

Molecularly targeted therapies in cervical cancer. A systematic review

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients

Predictive markers in the adjuvant therapy of non-small cell lung cancer

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8

Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer

Validation of a next-generation sequencing assay for the detection of EGFR mutations in cell-free circulating tumor DNA

Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients

Targeted therapies in lung cancer

Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study

mTOR inhibitors in breast cancer: A systematic review

Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test

Adjuvant Therapy in Patients With Completely Resected Non–small-cell Lung Cancer: Current Status and Perspectives

Suchergebnisse filtern